FdaApplication

ANDA 203482

Back to search

Identifiers

Properties

PropertyValue
applicant_nameAMNEAL PHARMACEUTICALS
application_typeANDA
approval_date2016-05-23

Products (4)

ProductActive ingredientStrengthDosage form
TEMAZEPAMTEMAZEPAM15MGCAPSULE;ORAL
TEMAZEPAMTEMAZEPAM22.5MGCAPSULE;ORAL
TEMAZEPAMTEMAZEPAM30MGCAPSULE;ORAL
TEMAZEPAMTEMAZEPAM7.5MGCAPSULE;ORAL

4 products